Document Detail

Effective date of requirement for premarket approval for cardiovascular permanent pacemaker electrode. Final rule.
MedLine Citation:
PMID:  22792583     Owner:  HSR     Status:  In-Process    
The Food and Drug Administration (FDA) is issuing a final rule to require the filing of a premarket approval application (PMA) or a notice of completion of a product development protocol (PDP) for the cardiovascular permanent pacemaker electrode. The Agency has summarized its findings regarding the degree of risk of illness or injury designed to be eliminated or reduced by requiring the device to meet the statute's approval requirements and the benefits to the public from the use of the device. This action implements certain statutory requirements.
Related Documents :
18187123 - Rearing of fabrea salina henneguy (ciliophora, heterotrichida) with three unicellular f...
10093333 - Preventing deaths in alaska's commercial fishing industry.
23565183 - Shift work or food intake during the rest phase promotes metabolic disruption and desyn...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Federal register     Volume:  77     ISSN:  0097-6326     ISO Abbreviation:  Fed Regist     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-07-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7808722     Medline TA:  Fed Regist     Country:  United States    
Other Details:
Languages:  eng     Pagination:  39924-7     Citation Subset:  T    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Budget Control Act implications for Medicare.
Next Document:  Dependency and indemnity compensation (DIC) benefits for survivors of former prisoners of war rated ...